Oncology
News
Cancer More Common in People With Sleep Apnea
Major Finding: People with obstructive sleep apnea were twice as likely to receive a cancer diagnosis and 10%-480% more likely to die of cancer (...
News
Don't Disregard High-Dose Brachytherapy for Skin Cancer
News
AMA Delegates Slam PSA, Mammography Screening Recs
News
OGX-427 Takes Aim at Novel Target in Prostate Cancer
Major Finding: At 12 weeks, 71% of patients on OGX-427 plus prednisone were progression free, compared with 40% on prednisone alone.Data Source:...
Commentary
Cost and Efficacy Issues Surround Biosimilars
News
Adding Carboplatin to Pemetrexed Buoys Survival in Lung Cancer Subset
Major Finding: Median overall survival increased from 5.6 months with pemetrexed alone to 9.1 months with the addition of carboplatin (HR, 0.57; P...
Conference Coverage
Docetaxel Bests Erlotinib in EGFR Wild-Type Lung Cancer
Major Finding: Medium progression-free survival was 3.4 months with docetaxel vs.
Conference Coverage
Selumetinib Cracks Door to Targeted Therapy for KRAS-Mutant NSCLC
Major Finding: The primary end point of overall survival was 5.2 months with docetaxel plus placebo and 9.4 months with docetaxel and selumetinib...
Conference Coverage
AACE: Does Diabetes Raise the Risk of Cancer?
Conference Coverage
Pemetrexed Maintenance Extends Survival of Advanced Lung Cancer
Major Finding: Median overall survival from randomization was 13.9 months with pemetrexed maintenance plus best supportive care vs.
News
Regorafenib Delays Progression of Refractory Metastatic GIST
Major Finding: Median progression-free survival was 4.8 months with regorafenib vs.